Pharmacovigilance Practice

Good Pharmacovigilance Practices (GVP) begins with the acquisition of complete information from spontaneous adverse event reports. Good Pharmacovigilance Practice and Pharmacoepidemiology in Risk Management is mainly to increase the probability of beneficial effects of a drug in a population than the probability of adverse effects The pharmacovigilance and clinical trials services providing corporations ought to have the Pharmacovigilance certification.
 
To know more details visit the link: Pharmacovigilance Conference

  • Good reporting practices
  • Interpreting safety signals

Related Conference of Pharmacovigilance Practice

July 27-28, 2026

19th World Drug Delivery Summit

Paris, France
July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy
September 14-15, 2026

6th International Conference on Pharmaceutical Chemistry

Paris, France
September 24-25, 2026

6th World Congress on Rare Diseases & Orphan Drugs

Paris, France
November 26-27, 2026

5th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 26-27, 2026

5th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
January 26-27, 2027

22nd Annual Meet on Pharmaceutical Sciences

Paris, France
April 27-28, 2027

10th European Biopharma Congress

Paris, France

Pharmacovigilance Practice Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in